Charm Therapeutics applies AI to complex protein interactions, locking down $50M A round
TechCrunch
JUNE 10, 2022
The world of AI-powered drug discovery keeps expanding as the capabilities of machine learning grow. “That’s really where we have innovated: we have built DragonFold, which is the first protein-ligand co-folding algorithm,” said Laskh Aithani, CEO and co-founder of Charm Therapeutics.
Let's personalize your content